Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.
Sakref C, Saby A, Rodriguez C, Ardin M, Moudombi L, Doffin AC, Gobbini E, Voissiere A, Besson L, Laoubi L, Böttcher J, Depil S, Hubert M, Bendriss-Vermare N, Caux C, Valladeau-Guilemond J.
Sakref C, et al. Among authors: besson l.
Nat Commun. 2025 Mar 28;16(1):3045. doi: 10.1038/s41467-025-58220-8.
Nat Commun. 2025.
PMID: 40155377
Free PMC article.